Fimmic Launches Aiforia™ Cloud, Bringing Self-Service Deep Learning AI to Digital Pathology

 Aiforia will be introduced at the USCAP Annual Meeting in Vancouver, March 18-21, 2018, booth #833

Fimmic, a forerunner in developing cloud-based, intelligent image analysis solutions to Digital Pathology, announces the launch of its new Aiforia™ Cloud. Aiforia, formerly known as WebMicroscope®, brings together its established deep learning artificial intelligence (AI) image analysis cloud solution with new self-service and automatized pathology image analysis capabilities.

The platform’s new Aiforia™ Create tools bring unique self-service capabilities by allowing users to generate their own deep learning algorithms. Users can train convolutional neural networks (CNN) to learn, detect and quantify specific features of interest in tissue images. With the algorithms’ ability to mimic the human observer in understanding the context in tissue, they can automatically and accurately perform laborious and complex image analysis tasks in a fraction of the time.

Aiforia’s use of CNNs means deep learning algorithms can be easily developed in just days or less, compared to the months needed for conventional machine vision approaches. In just a few simple steps, a user with no prior algorithm design experience can use Aiforia Create. The entire platform itself is simple, easily accessible and affordable with a SaaS mode. Users can deploy and use the platform easily with a browser, with no need to invest in local hardware or software.

“Working with the Aiforia Cloud gives my team new research approaches that have not been possible before,” said Johanna Arola, pathologist at Helsinki University Central Hospital. “The platform’s deep learning-based algorithms provide fast and consistent sample analysis, which helps us use our time effectively, and the cloud platforms enables all of our international team members to collaborate, no matter where they are.”

“Digitizing the field of pathology has been an important step forward for healthcare, but we’re once again poised for real disruption in the space,” said Kaisa Helminen, Fimmic CEO. “An aging population and rise in cancer prevalence, coupled with the radical innovation of AI technology, has created both a significant need and opportunity for digital pathology to evolve. At Fimmic, we are driven by the common goal of better and more accurate medical analysis, diagnoses and treatments, and we are proud to offer the first solution of its kind to bring deep learning AI to the fingertips of all pathologists and researchers, empowering users to explore and discover more with less time, money and effort.”

Fimmic will be demonstrating Aiforia™ Cloud at the USCAP Annual Meeting in Vancouver from March 18-21, 2018. Visit booth #833 to learn more.

Additionally, Fimmic will host a webinar on April 10th at 4PM GMT (5PM CEST, 11AM EDT, 8AM PDT) with a live demonstration and Q&A sessions. Register for the webinar here.

Link to webinar registration: https://register.gotowebinar.com/register/5689869708763122947.

About Fimmic

Fimmic, founded in 2013, is a spin-off company from the Finnish Institute for Molecular Medicine at the University of Helsinki. Fimmic’s unique Aiforia™ Cloud brings together Deep Learning -based Image Analysis and high-performance Cloud Computing. Formerly known as WebMicroscope, Aiforia Cloud is already used by more than 6,000 pathologists, researchers and pharmaceutical R&D teams to manage and share digital slide collections. The SaaS solution enables fast, accurate and affordable analysis support for every pathologist and medical researcher in tissue-based image analytics through a zero friction cloud deployment and intuitive online user interface.

Aiforia is currently sold with a Research Use status.

More information

www.aiforia.com
contact@fimmic.com